EU PHARMA COMPANIES MAYBE REQUIRED TO DISCLOSE SIDE-EFFECTS DATA, ECJ RULES
December 1st, 2014
THE EUROPEAN Court of Justice (ECJ) has ruled that European Union (EU) member states can insist pharma companies yield data of side-effects of their medicines, when demanded by a disgruntled patient. The ECJ was assessing whether member states could pass such laws under EU directive 85/374/EEC on consumer protection liability for defective products. The case, which sets an EU-wide precedent, focused on a German diabetic taking ‘Levemir’, manufactured by Denmark-based Novo Nordisk Pharma. It caused lipoatrophy, the loss of subcutaneous fat tissue. She was ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.